Literature DB >> 16858124

Sequence-based analysis of the CYP2D6*36-CYP2D6*10 tandem-type arrangement, a major CYP2D6*10 haplotype in the Japanese population.

Akiko Soyama1, Yoshiro Saito, Takashi Kubo, Atsuko Miyajima, Yasuo Ohno, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Hitonobu Tomoike, Shogo Ozawa, Jun-ichi Sawada.   

Abstract

The frequency of the CYP2D6*10 allele (100C>T) in the Japanese is relatively high (0.3-0.4), and the two *10-related genes, Ch1 (currently *10B) and Ch2 (*36), and their tandem arrangement Ch(2)-Ch(1) (*36-*10B) have been reported. Although the tandem form of *36-*10 is assumed to be a major form, no detailed information has been reported for its intervening and flanking regions. Thus in this study, the tandem-type *36-*10B and the single-type *10 were analyzed by long-range PCR and sequencing of the subsequent nested PCR products. The sequence of the entire *36-*10 region confirmed the recombination of CYP2D6*10 with CYP2D7P. Also, we found that most of the *10B-harboring haplotypes have the upstream *36 gene and that the majority of the remaining haplotypes are the single-type *10B. Haplotype frequencies of the single-type *10 and *36-*10B were 0.06 and 0.30, respectively, in the subjects analyzed. Additionally, several novel single nucleotide polymorphisms (SNPs) were found in the *36 region and several *36 haplotypes were identified. This sequence information is an important addition to the CYP2D6 sequence data that was obtained by the human genome project.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16858124     DOI: 10.2133/dmpk.21.208

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  11 in total

1.  Limited effects of frequent CYP2D6*36-*10 tandem duplication allele on in vivo dextromethorphan metabolism in a Japanese population.

Authors:  Kazuma Kiyotani; Makiko Shimizu; Toshio Kumai; Tetsuya Kamataki; Shinichi Kobayashi; Hiroshi Yamazaki
Journal:  Eur J Clin Pharmacol       Date:  2010-08-11       Impact factor: 2.953

2.  Identification of a novel non-functional CYP2D6 allele, CYP2D6*69, in a Caucasian poor metabolizer individual.

Authors:  Andrea Gaedigk; Dorothee Frank; Uwe Fuhr
Journal:  Eur J Clin Pharmacol       Date:  2008-09-17       Impact factor: 2.953

3.  Integrated CYP2D6 interrogation for multiethnic copy number and tandem allele detection.

Authors:  Wanqiong Qiao; Suparna Martis; Geetu Mendiratta; Lisong Shi; Mariana R Botton; Yao Yang; Andrea Gaedigk; Raymon Vijzelaar; Lisa Edelmann; Ruth Kornreich; Robert J Desnick; Stuart A Scott
Journal:  Pharmacogenomics       Date:  2018-12-06       Impact factor: 2.533

4.  CYP2D6 allele frequencies, copy number variants, and tandems in the population of Hong Kong.

Authors:  Wing Chan; Man S Li; Senthil K Sundaram; Brian Tomlinson; Pik Y Cheung; Chi H Tzang
Journal:  J Clin Lab Anal       Date:  2018-08-01       Impact factor: 2.352

5.  Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients.

Authors:  Kazuma Kiyotani; Taisei Mushiroda; Chiyo K Imamura; Naoya Hosono; Tatsuhiko Tsunoda; Michiaki Kubo; Yusuke Tanigawara; David A Flockhart; Zeruesenay Desta; Todd C Skaar; Fuminori Aki; Koichi Hirata; Yuichi Takatsuka; Minoru Okazaki; Shozo Ohsumi; Takashi Yamakawa; Mitsunori Sasa; Yusuke Nakamura; Hitoshi Zembutsu
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

6.  Determination of novel CYP2D6 haplotype using the targeted sequencing followed by the long-read sequencing and the functional characterization in the Japanese population.

Authors:  Koya Fukunaga; Eiji Hishinuma; Masahiro Hiratsuka; Ken Kato; Takuji Okusaka; Takeo Saito; Masashi Ikeda; Teruhiko Yoshida; Hitoshi Zembutsu; Nakao Iwata; Taisei Mushiroda
Journal:  J Hum Genet       Date:  2020-08-05       Impact factor: 3.172

Review 7.  Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

Authors:  Shu-Feng Zhou
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 8.  Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.

Authors:  P C D Bank; K E Caudle; J J Swen; R S Gammal; M Whirl-Carrillo; T E Klein; M V Relling; H-J Guchelaar
Journal:  Clin Pharmacol Ther       Date:  2017-10-10       Impact factor: 6.875

9.  Combination analysis in genetic polymorphisms of drug-metabolizing enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese population.

Authors:  Tomoko Ota; Yuka Kamada; Mariko Hayashida; Kyoko Iwao-Koizumi; Shigenori Murata; Kenji Kinoshita
Journal:  Int J Med Sci       Date:  2015-01-01       Impact factor: 3.738

10.  Results and challenges of Cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida population.

Authors:  Daria Salyakina; Sharmeen Roy; Weize Wang; Mailin Oliva; Rohan Akhouri; Ileana Sotto; Nicole Mulas; Rafaela Solano; José R Fernández; Stephanie Sanchez; Uzma Shamshad; Chad Perlyn; Jennifer McCafferty-Fernandez
Journal:  Mol Genet Genomic Med       Date:  2019-08-07       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.